Hybrid Quantum Mechanical/Molecular Mechanical Molecular Dynamics Simulations of HIV-1 Integrase/Inhibitor Complexes  by Nunthaboot, Nadtanet et al.
Hybrid Quantum Mechanical/Molecular Mechanical Molecular Dynamics
Simulations of HIV-1 Integrase/Inhibitor Complexes
Nadtanet Nunthaboot,* Somsak Pianwanit,* Vudhichai Parasuk,* Jerry O. Ebalunode,y James M. Briggs,y
and Sirirat Kokpol*
*Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand; and yDepartment of Biology and Biochemistry,
University of Houston, Houston, Texas USA
ABSTRACT Human immunodeﬁciency virus (HIV)-1 integrase (IN) is an attractive target for development of acquired immuno-
deﬁciency syndromechemotherapy. In this study, conventional and coupled quantummechanical andmolecularmechanical (QM/
MM) molecular dynamics (MD) simulations of HIV-1 IN complexed with 5CITEP (IN-5CITEP) were carried out. In addition to dif-
ferences in the bound position of 5CITEP, signiﬁcant differences at the two levels of theorywere observed in themetal coordination
geometry and the areas involving residues 116–119 and 140–166. In the conventional MD simulation, the coordination of Mg21
was found to be a near-perfect octahedral geometry whereas a distorted octahedral complex was observed in QM/MM. All of the
above reasons lead to a different pattern of protein-ligand salt link formation that was not observed in the classical MD simulation.
Furthermore to provide a theoretical understanding of inhibition mechanisms of 5CITEP and its derivative (DKA), hybrid QM/MM
MD simulations of the two complexes (IN-5CITEP and IN-DKA) have been performed. The results reveal that areas involving
residues60–68, 116–119, and 140–149were substantially different among the two systems. The two systems showsimilar pattern
of metal coordination geometry, i.e., a distorted octahedron. In IN-DKA, both OD1 and OD2 of Asp-64 coordinate the Mg21 in a
monodentate fashionwhereas onlyOD1 is chelated to themetal as observed in IN-5CITEP. Thehigh potency of DKAas compared
to 5CITEP is supported by a strong salt link formed between its carboxylate moiety and the ammonium group of Lys-159. Detailed
comparisons between HIV-1 IN complexed with DKA and with 5CITEP provide information about ligand structure effects on
protein-ligand interactions in particular with the Lys-159. This is useful for the design of new selective HIV-1 IN inhibitors.
INTRODUCTION
Acquired immunodeﬁciency syndrome (AIDS), caused by
human immunodeﬁciency virus (HIV), is an epidemic world-
wide disease. Combinations of drugs targeting reverse tran-
scriptase (RT) and protease (PR) enzymes, known as the highly
active antiretroviral therapy (HAART), is currently used for
the treatment of HIV-1 infection. However, the limitation of
RT and PR inhibitors in terms of their side effects and drug
resistance leads to an effort to develop new drugs to be a third
component of HAART. Thus, HIV-1 integrase (IN) has be-
come an attractive target for AIDS therapy. There is no known
similar enzyme in human, therefore, speciﬁc inhibitors of
HIV-1 IN are expected to have minimal side effects as com-
pared to other antiviral agents.
HIV-1 IN is a 32-kDa enzyme comprising three functional
domains, N-terminal (residues 1–50), catalytic core (residues
50–212), andC-terminal (residues 212–288). The catalytic res-
idues, Asp-64, Asp-116, and Glu-152, are in the catalytic core
domain coordinating one or two divalent metal ions. Diva-
lent metal ions, such as Mg21 or Mn21, are required for the
catalytic activity of IN. Although two metal ions have been
proposed to be present in the IN active site, as seen in avian
sarcoma virus (ASV) IN (1) a single metal is present in the
resolved x-ray structures of HIV-1 IN (2,3). Moreover, the
second metal has been proposed to present in the HIV-1 IN
active site once it binds with the substrate (4,5).
HIV-1 IN functions by catalyzing the insertion of viral
DNA, synthesized by the HIV-1 RT from viral RNA, into the
host chromosome using a two-step mechanism. In the ﬁrst
step, named 39-processing, IN removes a dinucleotide from
each 39-end of the viral DNA. In the next process, named
strand transfer, IN joins the previously processed recessed
39-ends to 59-positions on opposite strands of the target DNA,
across a ﬁve-basepair stretch. The ﬁnal step, which may not
involve IN, is the cleavage of the dinucleotide overhangs and
ligation. Subsites for 39-processing and strand transfer have
been proposed (6) based on the hypothesis that the 39-processing
step occurs in the active site area in the vicinity ofMg21 since
the divalent cation is critical for the 39-processing activity.
The 39-processing cavity is formed by residues Asp-64, Cys-
65, Thr-66, His-67, Glu-92, Asn-120, Phe-121, Asp-116, and
Mg21 ion whereas an area made by residues Gln-62, Ile-141,
Pro-142, Tyr-143, Gln-148, Ile-151, Glu-152, Lys-156, Asn-
155, and Lys-159 represents the strand transfer cavity.
During the last few years, a large number of compounds
have been reported to inhibit HIV-1 IN (7–11). Among the
several classes, the diketo acid is one of the most widely de-
veloped since this group of compounds shows high potency
and high selectivity. In this study, special attention is paid to
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the two diketo acid derivatives, 5CITEP and DKA (Fig. 1).
The general structure of 5CITEP is very similar to that of
DKA, except that the tetrazole ring is replaced by a carbox-
ylic acid group in DKA. Nevertheless these two compounds
differ in inhibition activity. In the presence of Mg21, DKA
is about 16-fold and 50-fold more active than 5CITEP for
39-processing and strand transfer reactions, respectively (5).
In addition, the inhibitory activities of these two compounds
are metal dependent (4,5).
Several computational methodologies, including molecular
docking (6,10,12–15) and pharmacophore modeling (16–19)
have been employed to elucidate the binding mode of diketo
acid compounds. Many of them reveal that the mechanism of
the inhibition of this class of compound is due to the chela-
tion of the keto-enol group by the divalent metal ion. Further-
more, although the x-ray structure of the complex between
HIV-1 IN and 5CITEP is available (20) its mechanism of
action is not yet fully understood. In the cocrystal complex,
5CITEP is located in the center of the active site, lying be-
tween Asp-64, Asp-116, and Glu-152. The keto-enol motif
of 5CITEP forms a hydrogen-bond with Glu-152 whereas all
four nitrogen atoms in the tetrazole ring form hydrogen-
bonds with Asn-155, Thr-66, Lys-159, and Lys-156. The in-
dole ring of the ligand is pointed toward Gln-148. However,
this bound conformation of 5CITEP in the cocrystal structure
is possibly not in the bioactive form because of the crystal
packing effects that arise from the close contact between both
subunits A of the dimeric form of HIV-1 IN. Furthermore,
two 5CITEP molecules hydrogen-bond with one another as
they bind to two active sites. This is supported by several
docking calculations (5,21,22) of 5CITEP into the HIV-1 IN
catalytic core domain showing that the bound conformation
of 5CITEP in the cocrystal structure could not be reproduced.
Because the mechanism of action of the diketo acid com-
pound probably involves the metal ion, metal-binding models
of diketo acid derivatives and diketo-like compounds have
been recently proposed (4,23–26) suggesting that the Mg21 is
chelated by ligands via their keto-enol or carboxylic acid
moieties. In our previous work (N. Nunthaboot, S. Pianwanit,
V. Parasuk, J. O. Ebalunode, J. M. Briggs, and S. Kokpol,
unpublished data), we also have proposed models of metal-
ligand binding based on the assumption that: i), ligands
(5CITEP and DKA) are in their dianionic form based on the
experimental studied by Maurin and co-workers (27); ii), only
one Mg21 is modeled in the active site since the DNA
substrates are not included in our structures; and iii), the keto-
enolate group of the ligand directly forms a coordination
complex with Mg21. A schematic representation of the ligand
binding to the HIV-1 IN active site is illustrated in Fig. 2.
Since 5CITEP and DKA are positioned in the 39-processing
cavity where the Mg21 is located, the proposed models of
ligand binding should represent their inhibition mechanisms at
the 39-processing step that requires divalent metal ion. Our
proposed metal-ligand models are the initial structures used in
this study.
Although molecular dynamics (MD) simulations of either
HIV-1 IN complexed with inhibitor or the free enzyme have
been carried out (28–33) to the best of our knowledge, this is
the ﬁrst time combined quantum mechanical/molecular me-
chanical (QM/MM) simulations have been reported for an
HIV-1 IN-inhibitor complex. In addition, ligand orientations
as well as protein-ligand interaction modes are different from
those used in the classical MD simulations. In the QM/MM
concept, the system is partitioned into a QM region and a clas-
sical MM region (34). An interesting species (such as ligand
or protein active site), the QM region, is treated quantum
FIGURE 1 Chemical structure and atomic deﬁnition of (a) 5CITEP and
(b) DKA.
FIGURE 2 Schematic drawing of proposed metal-ligand binding of HIV-1
IN-inhibitor complexes. QM regions used in QM/MM calculation are en-
circled. HQ refers to hydrogen link atom HQ type, which is added between
the a-carbon and b-carbon of both Asp-64 and Asp-116.
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mechanically whereas the rest of the system (surrounding
amino acids and solvent), the MM region, is described by clas-
sical molecular mechanics. Ideally, the QM region should be
treated by ab initio (35) or density functional theory (36),
however the computational cost of such a high level of QM is
prohibitively expensive, especially when applied to signif-
icant portions of an enzyme’s active site. In this study, a semi-
empirical approach (34) was used for the QM region.
The main aim of this study was to investigate structural
and dynamical properties of HIV-1 IN complexed with li-
gands. Hybrid QM/MM simulations of the HIV-1 IN com-
plexed with DKA (IN-DKA) or with 5CITEP (IN-5CITEP)
were carried out. An effort has been made to explain the dif-
ference in inhibitory potency of the two compounds. More-
over, to provide a point of comparison with conventional MD,
we also performed a classical MD simulation of IN-5CITEP
and the results obtained from the two levels of theory (MM
and QM/MM) were compared. A detailed analysis suggests
that a hybrid QM/MM is most appropriate for the complexes
used in this work.
METHODOLOGY
System preparation and conventional
MD simulation
Initial structures of the two systems of HIV-1 IN-inhibitor complexes were
taken fromour preliminarywork (N.Nunthaboot, S. Pianwanit, V. Parasuk, J.
O. Ebalunode, J. M. Briggs, and S. Kokpol, unpublished data). In the ﬁrst
system, IN-5CITEP, HIV-1 IN is in complex with 5CITEP and in the second
system, IN-DKA, the protein is in complex with DKA. We give a brief
summary of the important details of the starting structures. In both systems,
Mg21 is octahedrally coordinated with the OD1 atoms of residues Asp-64,
Aps-116, O atoms of water molecules (water No. 1 and water No. 2) and O
atoms belonging to the keto-enolate moiety of the ligands whose dianionic
form was used (Fig. 2). No unusual amino acid ionization states were iden-
tiﬁed through application of the ionization state prediction methodology in
the UHBD program (37) (i.e., Lys and Arg¼11, Asp and Glu¼1, His¼ 0).
In each system, the complex was solvated with a 28-A˚ radius sphere of
TIP3P water centered on the Mg21 ion in the active site. Overlapping water
molecules whose oxygen atoms were closer than 2.8 A˚ to any other heavy
atom were removed. Subsequently, the added water molecules were energy
minimized using the two series of 300 steps of steepest descent (SD) fol-
lowing by two series of 500 steps of adopted basis Newton Raphson (ABNR)
to relieve steric clasheswithin the system.The solvent spherewas equilibrated
(at 300K) for 25 ps with protein and ligand ﬁxed. These solvation procedures
(sphere addition, water deletion, and equilibration) were repeated several times
to avoid solvent cavities. As a result, the IN-5CITEP system contained 2406
solute atoms (protein, Mg21, 5CITEP, two ‘‘catalytic’’ water molecules) and
7371 water atoms, whereas for the IN-DKA system, the numbers of solute
(protein,Mg21, DKA, two catalytic watermolecules) and solvent atomswere
2404 and 7365, respectively.
In each case, the enzyme-inhibitor complex was energetically minimized
using the two series of 300 steps SD and 1000 steps ABNR. The system was
further slowly heated from 10 to 300 K in three 10-ps intervals, 10–100 K,
100–200 K, and 200–300 K. Afterward, the complex was equilibrated for
300 ps and the resulting structure was consequently used as the starting
conﬁguration for QM/MM MD simulation. For the conventional MD
simulation, the system was further equilibrated with stochastic boundary
conditions (38) over 1000 ps and the production run was collected from 400
to 1000 ps.
All calculations were conducted using the CHARMM suite of programs,
version 29b2 (39). For classical MD simulation, CHARMM parameters for
both ligands were constructed by analogy with similar molecular structure in
the all-atom CHARMM27 parameter set. The torsional energies for the C5-
C6 and C7-C8 bonds (see Fig. 1) were slightly increased to keep the O1 and
O2 atoms coplanar with the C4, C5, C7, and C8 atoms. Atomic net charges
were obtained by the restricted electrostatic potential ﬁtted charges at the
HF/6-31G (d). More details of ligand setup are provided in Supplementary
Material. A stochastic boundary molecular dynamics (38) simulation was
employed. The 28-A˚ sphere was subdivided into the reaction zone (0–22 A˚)
treated by Newtonian dynamics and a buffer zone (22–26 A˚) treated by
Langevin dynamics. Protein atoms within the buffer region were harmon-
ically restrained to their minimized positions. Friction coefﬁcients of 250/ps
and of 62/ps (40) were used for nonhydrogen protein atom and water oxygen
atoms, respectively. Amino acid residues that were more than 26 A˚ away
from the center of the sphere were restrained during the calculations. To pre-
vent escape of water molecules, a deformable boundary potential (41,42) at
28 A˚ was employed. The SHAKE (43) algorithm was employed to constrain
all bond containing hydrogen atoms. The time step was 1 fs. A nonbonded
cutoff with an atom switching function in the region from 8 to 13 A˚ was used
to smoothly scale down the interaction to zero at 13 A˚.
QM/MM setup
The QM region contains the acetate side chains of Asp-64 and of Asp-116,
two ‘‘catalytic’’ water molecules, an Mg21 ion, and the ligand totaling 47
and 45 atoms, including two H-link atoms, in the IN-5CITEP and IN-DKA
systems, respectively (Fig. 2). To ensure that the MM charges were treated
consistently in the Hamiltonian for the QM atoms, all QM atoms were de-
ﬁned as a single group. The hydrogen link atoms, HQ type (44), were added
between the Ca and the Cb of aspartic acids to saturate the QM and MM
boundary. The overall charge in the QM region was 2e for both systems.
The QM atoms were described by the semiempirical PM3 method (45–47)
whereas the other atoms were treated by a classical CHARMM22 force ﬁeld
(48). QM/MM energy minimization (250 steps of SD followed by 750 steps
of ABNR) was performed for each system. Afterward, the QM/MM MD
simulation was conducted using the same conditions as the classical MM
simulation and was run for 1200 ps, with the ﬁnal 600 ps taken as the pro-
duction data.
RESULTS AND DISCUSSION
In this section, comparison of the results between MM and
QM/MM calculations of the IN-5CITEP system was made to
elucidate the differences between the two levels of theories.
Then, the results of the QM/MM simulations between the
IN-DKA and IN-5CITEP complexes were analyzed and dis-
cussed to describe their structural and dynamical properties.
Comparison of IN-5CITEP using MM and QM/MM
force ﬁelds
Structural dynamics of the HIV-1 IN
To compare the use of MM and QM/MM parameters, MD
simulations of IN-5CITEP based on classical and QM/MM
parameters were examined. Trajectory analyses were carried
out on the production runs, i.e., 400–1000 ps and 600–1200 ps
for the conventional MD and hybrid QM/MMMD simulations,
respectively. To assess the stability of the MM and QM/MM
trajectories, the root mean square deviations (RMSD) for all
heavy atoms were plotted versus simulation time. Fig. 3 a
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shows RMSD with respect to the average structures of the
two simulations. It can be clearly seen that both simulations
produced stable trajectories as indicated by their small RMSDs
(;0.6 A˚). The small RMSD ﬂuctuation of the two trajec-
tories during the course of dynamics runs conﬁrms they were
reasonably stable systems.
To ﬁnd out which part of protein shows high ﬂexibility,
the root mean square ﬂuctuation (RMSF) of backbone atoms
for each residue during the MD simulations was monitored,
as depicted in Fig. 4 a. The MM results revealed that the
largest ﬂuctuations of the protein are seen in the two areas
corresponding to residues 116–119 and residues 140–149.
Meanwhile, the QM/MM calculation showed that only the
loop region 140–149 was found to be ﬂexible whereas res-
idues 116–119 were quite rigid throughout the simulation.
The superimposition of the average structures of the pro-
tein taken from the two simulations is illustrated in Fig. 5 a.
The RMSD of all heavy atoms in the protein between the two
simulations is 1.36 A˚. As can be clearly seen, two signiﬁcant
differences in protein structure between the two levels of
theory are the conformations in the area involving residues
116–119 and residues 140–149. The RMSD (all heavy atoms)
of amino acid residues 116–119 and 140–149 of the average
structures between MM and QM/MM simulations are 1.24
and 1.77 A˚, respectively. The conformation of Asp-64 using
MM parameters was somewhat similar to that of using QM/
MM whereas Asp-116 adopted a different orientation in the
two levels of calculations. Due to the adjustment of Mg21
and 5CITEP to the new equilibrated state of the system, Asp-
116 adopted its conformation to preserve the interaction with
this catalytic metal ion. This leads to the conformational dif-
ference of the region containing residues 116–119. In this
area, we note that Gly-118 exhibited the highest ﬂuctuation.
In the conventional MM simulation, this loop adopted a con-
formation away from residues Phe-121 and Thr-122, making
it difﬁcult for Gly-118 to form hydrogen-bonds with the above-
mentioned two amino acids (Fig. 5 b). An analysis of hydrogen-
bonding shows that hydrogen-bonds occur through 20% of
the simulation between Gly-118 and Phe-121, and 30% of the
time between Gly-118 and Thr-122. On the contrary, in the
FIGURE 3 Root-mean-square deviations of all heavy atoms with respect
to the average structure versus simulation time. Panel a compares heavy
atom RMSDs of IN-5CITEP obtained from conventional MD and QM/MM
MD simulations. Panel b compares heavy atom RMSDs between IN-DKA
and IN-5CITEP taken from a hybrid QM/MM MD simulations.
FIGURE 4 Average root-mean-square ﬂuctuation (RMSF) of protein back-
bone atoms as a function of residue number. Panel a compares the RMSF of
protein structure of IN-5CITEP complex taken from the classical and hybrid
QM/MM MD simulations. Panel b compares the RMSF of protein back-
bones of IN-DKA and IN-5CITEP complexes obtained from QM/MM MD
simulations.
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QM/MM MD simulation, Gly-118 is located close to Phe-
121 and Thr-122. The carbonyl oxygen of Gly-118 is po-
sitioned between the NH atoms of Phe-121 and Thr-122,
thus, it is easier for Gly-118 to establish such hydrogen-
bonds (Fig. 5 c). These hydrogen-bonds are almost always
present during the dynamics simulation, indicated by 83%
and 97% of an occurrence of hydrogen-bond between Gly-
118 and Phe-121 and between Gly-118 and Thr-122,
respectively. Apparently, the rigidity of Gly-118 observed
in QM/MM is due to hydrogen-bond between its carbonyl
oxygen and the NH belonging to Phe-121 and Thr-122.
We now turn our attention to the loop involving residues
140–149. The large ﬂexibility of this loop is not surprising
since it is located at the surface of the protein and is ﬂanked by
Gly residues. Moreover, the observed high mobility of this
loop is in agreement with the previous MD simulations of
HIV-1 IN andwith crystal structures (i.e., this loop is typically
not resolved) (20,28,30). It is worth mentioning that although
loop 140–149 is very ﬂexible, it does not undergo the same
conformational changes in the two simulations (Fig. 5 d). The
MM results show larger ﬂuctuations of this loop than that ob-
served in the QM/MM calculation. The pink and blue ribbons
represent theMMandQM/MMresults, respectively, with key
residues rendered as stick models. As can be seen, the dif-
ferent conformation of this particular ﬂexible loop resulted in
a variation of the conformation of the a4-helix of the region
consisting of residues 148–166. Amino acids located in this
a4-helix take on very different conformations, which leads to
different interactions between the ligand and the protein, espe-
cially in salt-bridge interactions, as discussed in the next section.
Mg21 coordination and inhibitor binding mode
One signiﬁcant difference observed between the two levels
of theory is the coordinating distances between Mg21 and its
chelated oxygen atoms. The key distances between the catalytic
FIGURE 5 (a) Superimposition of the protein conformation of the average structure obtained from conventional MD (light gray) and taken from a combined
QM/MM MD calculation (dark gray). Residues Asp-64, Asp-116, and inhibitors are shown as stick models whereas Mg21 ion and the catalytic water
molecules are displayed in balls. Panels b and c display hydrogen-bonds between amino acids located in 116–119 obtained from conventional and QM/MM
MD simulations of IN-5CITEP complex, respectively. (d) Stereo view of the catalytic loop region (residues 140–149) and the a4-helix. Selected residues and
inhibitors are displayed in stick models. The distances between ligand and Lys-159 are shown in dotted lines. The ﬁgures were generated using VMD (54).
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metal ion and the coordinated oxygen atoms were plotted as
a function of simulation time, as illustrated in Fig. 6. For the
classical MD simulation, the Mg21 was octahedrally coor-
dinated by the two aspartate residues (Asp-64 and Asp-116)
via their OD1 atoms, the oxygen atoms (O1 and O2) of the
keto-enolate moiety of 5CITEP, and the two oxygen atoms
of the catalytic water molecules (OW1 of water No. 1 and
OW2 of water No. 2). The chelate distances between Mg21
and the aforementioned oxygen atoms ﬂuctuate in the range
of 1.8–2.0 A˚ (Fig. 6 a), which are close to a perfect octa-
hedral geometry. However, in the QM/MM simulation, the
Mg21 formed a distorted octahedral complex with the sur-
rounding oxygen atoms. The distances between Mg21 and
four oxygen atoms (O1, O2 of 5CITEP, OD1–Asp-116, and
OW2) are;1.8 A˚ whereas the other two (Mg21–OD1–Asp-
64 and Mg21–OW1) are;2.5 A˚, as depicted in Fig. 6 b. The
different coordination geometry of Mg21 produced by MM
and QM/MM leads to different conformations of Asp-116 and
induces a different conformation of loop 116–119, as men-
tioned earlier.
We next turn to an analysis of inhibitor binding mode. Both
MM and QM/MM results showed that 5CITEP occupied the
active site region of HIV-1 IN, although with a somewhat dif-
ferent position. Generally, 5CITEP shared common features
of binding in which the keto-enolate motif directly interacted
with the Mg21 ion with the tetrazolate ring pointed toward
the region involving residues Asn-155, Lys-156, and Lys-159
(Fig. 5 d). The salt bridge between the ligand and the enzyme
was monitored during the course of the MD trajectory. Sur-
prisingly, no salt link was observed between the protein and
5CITEP in the classical MD simulation. This is because Lys-
159 is located far from 5CITEP (;6.8–9 A˚; Fig. 7 a), hence,
the tetrazolate motif of the ligand is not able to form a salt
bridge with this particular residue. On the other hand, in the
QM/MM trajectory, the ligand adopted an orientation allow-
ing it to make this type of interaction with Lys-159. This is
supported by a plot of distance versus simulation time be-
tween the tetrazolate anion and the ammonium group of Lys-
159, as demonstrated in Fig. 7 b.
To further examine the mobility of 5CITEP, a detailed dis-
cussion is focused on the conformational changes of torsional
angles Tor1 (C3-C4-C5-C6) and Tor2 (C6-C7-C8-N9) (de-
ﬁned in Fig. 1). Remarkable differences were observed for
the angle Tor2 whereas no signiﬁcant difference was found
for the angle Tor1 (Fig. 8, a and b). For angle Tor1, both the
MM and QM/MM simulations show only one sharp peak at
;0 suggesting the single preferential conformation of the
indole ring of 5CITEP. During the simulation period, the in-
dole ring of the ligand always maintains a coplanar con-
formation relative to the keto-enolate motif. Additionally,
the MM results indicated again a single preferential confor-
mation of the tetrazolate ring of 5CITEP, as evidenced by the
angle Tor2 at;6180. On the other hand, the QM/MMMD
simulation produced two favorable conformations of the tet-
razolate ring. The ﬁrst conformation corresponds to Tor2 at
from about 180 to 100 and another one corresponds to
0–90. The broader and higher peak of Tor2 at 0–90 indi-
cated higher mobility and higher probability of ﬁnding this
conformation. The observation of double peaks in QM/MM
might be due the smaller repulsion between the negatively
charged group of 5CITEP and the surrounding amino acids
such as Glu-152 (tetrazolate–Glu-152, ;9.0 A˚). It is ap-
parent that atomic charges are better distributed in QM/MM,
so it shows the smaller repulsion. In contrast, MM has more
FIGURE 6 Time evolution of the interatomic distances between Mg21
and its coordinating atoms obtained from (a) conventional MD of IN-
5CITEP, (b) QM/MM of IN-5CITEP, and (c) QM/MM of IN-DKA.
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localized charges, hence, the repulsion between the tetrazo-
late anion and neighboring amino residues (tetrazolate–Glu-
152, ;4.5 A˚) is stronger. The planar orientation presumably
has the lowest repulsion. The tetrazolate ring therefore re-
mains at this position for the whole period of simulation.
This leads to the ﬁnding of a single sharp peak of Tor2 in the
classical MD simulation.
It is obvious that conventional and coupled QM/MM MD
simulations reveal somewhat different structural and dynam-
ical behaviors for the HIV-1 IN-5CITEP complex. It has been
reported that mixed QM/MM approaches exhibited advan-
tages over classical force ﬁelds (49,50). QM/MM yields the
results much closer to experimental data than those of MM
force ﬁelds. Thus a combined QM/MM has been selected to
study HIV-1 IN-ligand complexes that will be discussed in
depth below.
Comparison of QM/MM results between IN-DKA
and IN-5CITEP
Stability of MD trajectories
The stability of the MD trajectories of the two systems was
evaluated by plotting of RMSD values to their average struc-
tures (Fig. 3 b). The mean RMSD value of both systems
exhibits convergence to ;0.6 A˚. The steady and small mag-
nitude of RMSD ﬂuctuation suggests that the overall struc-
ture of the protein remained stable over the course of the MD
simulations. Therefore, our MD trajectories should provide a
suitable basis for more detailed analyses.
Residue ﬂuctuation
For each system, a detailed analysis of RMSF of protein
backbone atoms for each residue is illustrated in Fig. 4 b. The
remarkable differences between IN-DKA and IN-5CITEP
were again observed in residues 116–119, which are located
in the 39-processing cavity, and the loop residues 140–149.
In the former loop, Asp-116 andAsn-117 of the IN-DKA com-
plex undergo large amplitude movement during the trajectories,
whereas this motion is small in the IN-5CITEP complex. Re-
garding loop residues 140–149, although it was found to be
very ﬂexible in the two systems, this catalytic loop region
exhibited different conformational changes in the two com-
plexes. The IN-DKA complex exhibited a greater ﬂuctuation
of residue Gln-148 compared to that in the IN-5CITEP system.
Structural difference between IN-DKA and IN-5CITEP
The superimposition of the average structure between IN-
DKA and IN-5CITEP is given in Fig. 9. The RMSD of heavy
atoms in the protein between the two complexes is 1.34 A˚
suggesting a signiﬁcant difference of the protein structure.
As can be seen in Fig. 9, three apparent differences in the
HIV-1 IN structure between the IN-DKA and IN-5CITEP
complexes are noticeable around regions formed by residues
FIGURE 7 Plots of the salt link distances between the negatively charged
group of ligand and the ammonium group of Lys-59. The distance between
tetrazolate ring of 5CITEP and the ammonium nitrogen of Lys-159 taken
from the conventional MD is shown in panel a, whereas that from QM/MM
is given in panel b. Panel c shows the distance between carboxylate oxygens
of DKA and the terminal ammonium nitrogen of Lys-159.
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60–68, 116–119, and 140–149. In the IN-DKA complex, the
side chains of both Asp-64 and Asp-116 are almost perpen-
dicular to the plane deﬁned by the keto-enolate motif of DKA
whereas these two residues are mostly horizontal to the plane
of the ligand in IN-5CITEP. The adapted side chain of Asp-
64 in IN-DKA allows its OD1 and OD2 atoms to coordinate
the divalent metal ion (see Fig. 6 c). Unlike IN-DKA, in IN-
5CITEP, only the OD1 atom of Asp-64 chelates with the
Mg21 ion (see Fig. 6 b). The conformational difference of
the Asp-64 side chain in the two complexes affects the length
of the b1-sheet, which consists of seven residues (60–66) in
IN-DKA and nine residues (60–68) in IN-5CITEP.
In addition, Asp-116 in the IN-DKA complex adapted its
side-chain conformation to allow a hydrogen-bonding net-
work to form between their OD1 and OD2 atoms and OW2 of
water No. 2. In contrast, in the IN-5CITEP complex only the
OD1 of Asp-116 was hydrogen-bonded to OW2. Thus, the
HIV-1 IN-DKA complexwas stabilized by a larger number of
hydrogen-bonds with water than those in the IN-5CITEP
system. Furthermore, the conformational difference of Asp-
116 results in conformational changes in residues 117–119 in
the IN-DKA complex.
The ﬁnal substantial differencewas detected in the catalytic
loop region involving residues 140–149. In fact, this loop is
very ﬂexible in nature (residues 140 and 149 are glycines) and
different crystal structures of HIV-1 IN exhibit various con-
formations of this particular loop, and in many cases, absence
of coordinates as it as too ﬂexible. The heavy atom RMSD
value of amino acids 140–149 between the average structure
of IN-DKA and IN-5CITEP was 3.08 A˚ indicating a large
difference of the catalytic loop between the two complexes,
especially Gln-148 (RMSD ¼ 0.71 A˚). It has been hypoth-
esized that Gln-148 is involved in the position of viral DNA
binding before strand transfer into host DNA (51), thus the
behavior of this residue might be crucial for DNA binding.
For IN-5CITEP, the rigidity of Gln-148 occurs because the O
of Gln-148 is capable of forming a hydrogen-bond with the
NH of Gln-146 (20%) and with the NH of Glu-152 (80%)
more than that found in IN-DKA(O (Gln-148)–NH(Glu-152)¼
70%). This hydrogen-bond formation was also observed in
the previously reported conventional MD simulations (28).
One remarkable observation between the two complexes is
the length of thea4-helix residues,which probably arose from
the conformational change of Gln-148. This helix in IN-DKA
spans residues 149–166, which is one residue shorter than that
in IN-5CITEP (residues 148–166). In the x-ray structure
(1QS4) as well as in the wild-type model of the conventional
MD simulation (28) of the x-ray complex structure of HIV-
1 IN-5CITEP, this helix involves residues 150–166 and 149–
165, respectively. Moreover, the instability of this helical
behavior was also observed in the conventional MD simula-
tion of the apoHIV-1 IN catalytic core domain containing one
Mg21 (33).
Inhibitor binding mode/structural features of the inhibitor
It is clear from Fig. 9 a that both DKA and 5CITEP occupied
nearly the same region in the active site of HIV-1 IN and they
FIGURE 8 Comparison of the dis-
tributions of torsional angles (a) Tor1
and (b) Tor2 of 5CITEP using MM and
QM/MM. Comparison of the distribu-
tions of torsional angles (c) Tor1 and
(d) Tor2 of both DKA and 5CITEP
taken from QM/MM MD simulation.
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showed a similar pattern of inhibitor binding orientation. For
each system, the keto-enolate moiety of the ligand chelated
the Mg21 ion whereas the chloroindole ring was located close
to residues Thr-115, Asn-117, and Gly-118. An electrostatic
interaction was also observed between the chlorine atom in
the indole ring and the amide group of Asn-117. The NH of
the indole ring of the two ligands is exposed to solvent and
does not make contact with any residue. Furthermore, the car-
boxylate group of DKA was pointed toward Lys-159 whereas
5CITEP oriented its tetrazolate anion toward this residue.
The salt bridges were observed between the ammonium group
of Lys-159 and the carboxylate (DKA) or the tetrazolate ring
(5CITEP), which will be discussed in the ‘‘Salt-bridge anal-
ysis’’ section.
To further investigate the structural changes of ligands, the
torsional angles Tor1 (C3-C4-C5-C6) and Tor2 (C6-C7-C8-
O9, C6-C7-C8-N9), denoted in Fig. 1, of DKA and 5CITEP
were statistically analyzed as a population frequency (Fig. 8).
The Tor1 distribution peaks of the DKA and 5CITEP mostly
overlap whereas the Tor2 angles do not. Both DKA and
5CITEP produced a single preferential coplanar conforma-
tion of indole ring, as evidenced by the only one peak for
Tor1 at ;0 (Fig. 8 c). For the torsional angle Tor2, a single
preferential conformation of the carboxylate moiety of DKA
was represented by a single sharp peak at;120 (Fig. 8 d).
This sharp and pronounced peak implied a low ﬂexibility of
the carboxylate functional group in a narrow range. Mean-
while, 5CITEP yielded two preferential conformations of the
tetrazole ring, as mentioned in the ‘‘Mg21 coordination and
inhibitor bindingmode’’ section, i.e., two broad peaks at Tor2¼
from 180 to 100 and at Tor2 ¼ 0–90. At Tor2 ¼ from
180 to 100, the N10 of the tetrazole ring was close to
Lys-159 whereas at Tor2 ¼ 0–60, the N11 was close to the
same residue. This suggests that the tetrazolate ring of 5CITEP
might alternate between two conformations in the binding
pocket and also supports the ﬁnding that either N10 or N11
of 5CITEP can make a salt link with Lys-159. The higher
peak at Tor2 ¼ 0–90 indicates a higher probability of ﬁnd-
ing the N11 in a salt bridge with Lys-159 as compared to
N10. According to the observations above, it is worth noting
that the rigidity of Tor2 in DKA is probably due to the ex-
istence of a stronger salt bridge to Lys-159 for the entire sim-
ulation. In contrast, the tetrazolate moiety of 5CITEP formed
a weaker salt link with Lys-159.
Mg21 coordination
To explore the dynamical properties of the divalent cation
and its coordination state, the interatomic distances between
Mg21 and the chelating oxygen atoms are plotted as a func-
tion of simulation time (Fig. 6, b and c). For IN-DKA, there
are seven oxygen atoms (OD1-Asp-64, OD2-Asp-64, OD1-
Asp-116, OW1, OW2, O1, and O2 of DKA) whose distances
are able to coordinate with the metal ion. The distances be-
tween Mg21 and OD1-Asp-64, OW2, O1, and O2 were
observed at ;1.8 A˚ whereas the other three (Mg21–OD2–
Asp-64, Mg21–OD1–Asp-116, and Mg21–OW1) were found
to be 2.5 A˚ (Fig. 6 c). These coordination distances were stable
along the whole trajectory. It appears that the Mg21 bound
tightly with the OD1-Asp-64, OW2, O1, and O2 of DKA, as
indicated by their shorter distances (1.8 A˚). The Mg21 forms
a distorted octahedral complex in which the carboxylate group
of Asp-64 is twisted toward the catalytic metal ion, allowing
both OD1 and OD2 to chelate the Mg21 in a monodentate
conﬁguration (Fig. 9 b).
For IN-5CITEP, Mg21 yields a somewhat similar pattern
of Mg21 coordination state as found in IN-DKA. As mentioned
FIGURE 9 (a) Superimposition of average structure obtained from QM/
MM MD simulations between IN-DKA (cyan) and IN-5CITEP (ice blue).
Binding modes of DKA (b) and 5CITEP (c) in the HIV-1 IN active site.
Mg21 ion is displayed as a green ball. The coordinating distances between
Mg21 and its chelating atoms are represented in dotted lines. The ﬁgures were
generated using VMD (54).
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above (section MM), Mg21 is chelated by six oxygen atoms
(O1-Asp-64, OD1-Asp-116, OW1, OW2, O1, and O2 of
5CITEP). In IN-5CITEP, Asp-64 uses only its OD1 atom to
chelate the Mg21 (Mg21–OD2–Asp-64¼ 4.5 A˚) whereas both
OD1 and OD2 were seen to coordinate the divalent cation in
IN-DKA. The coordination distances were 1.8 A˚ (Mg21–
OD1–Asp-116, Mg21–OW2, Mg21–O1, and Mg21–O2)
and;2.5 A˚ (Mg21–OD1–Asp-64 andMg21–OW1) (Fig. 6 b).
In this system, the Mg21 is tightly bound with the OD1 atom
of Asp-116 rather than OD1 of Asp-64 (found in IN-DKA).
This distorted octahedral geometry of Mg21 coordination (Fig.
9 c) persists for the entire course of the simulation.
It is worth noting that besides its catalytic role, the Mg21
also plays a structural role. In the HIV-1 IN active site, two
Asp residues (Asp-64 and Asp-116) and the keto-enolate mo-
tif of the inhibitor are close to each other and form a carbox-
ylate cluster, thereby generating an excess of negative charge
in the binding pocket. The positive charge of Mg21 is nec-
essary to stabilize the carboxylate cluster by diminishing the
electrostatic repulsion between these oxygen atoms.
Salt-bridge analysis
Ionic interactions play a critical role in biological systems,
therefore, a detailed analysis of salt-bridge formation between
HIV-1 IN and ligands was carried out for the dynamics tra-
jectories. The distances between the negatively charged group
(carboxylate or tetrazolate) of ligand and the ammonium group
of Lys-159 as a function of simulation time were plotted in
Fig. 7. In IN-DKA, the average distances between the neg-
atively charged group of the ligand (O9 and O10) and the
ammonium nitrogen (NZ) of Lys-159 is;2.86 0.17 A˚ (Fig.
7 c) implying that this strong salt-bridge ﬁndingwas observed
throughout the simulation period. In contrast, there is a weaker
ionic interaction between the tetrazolate ring of 5CITEP and
the Lys-159 during the ﬁrst 200 ps of the simulation (Fig. 7 b).
Within this period, the average distances between the tetra-
zolate ring and Lys-159 (NZ) are longer than;4 A˚ (N10–NZ¼
5.216 0.57 and N11–NZ¼ 4.596 0.52). For the remainder
of the simulation, the tetrazolate ring of 5CITEPmoved closer
to Lys-59 (N10–NZ ¼ 4.07 6 0.69 and N11–NZ ¼ 3.97 6
0.57), thus, the ionic interaction becomes stronger as com-
pared to that found in the early stage of the production phase.
It should be mentioned that although an ionic interaction be-
tween 5CITEP and Lys-159 can occur, it is weaker than those
observed in the IN-DKA complex.
To clearly demonstrate the dynamic nature of the salt links
between HIV-1 IN and the two inhibitors, snapshots were taken
from trajectories of IN-DKA and IN-5CITEP complexes and
are given in Fig. 10. In both complexes, only residue Lys-
159 was found to form a salt link with ligands. In IN-DKA,
the ammonium group of Lys-159 interacts with the carbox-
ylate moiety of DKA (Fig. 10 a) whereas that of the residue
interacts with the tetrazolate ring as found in IN-5CITEP
(Fig. 10 b). A hydrogen-bond was observed between bulk
water and the NH of indole ring of inhibitors in the two
systems. In addition, the ligand also formed hydrogen-bonds
with the bridging water in the active site of HIV-1 IN, as
discussed in the next section. It is worth mentioning that the
strong salt link between Asp-64 and Lys-159 was detected in
the IN-5CITEP complex (Fig. 10 b). Meanwhile, the salt link
between these two amino acids was not observed in the IN-
DKA complex because of the long distance (longer than 6.5
A˚) between these two residues.
According to the existence of a strong salt link between
DKA and HIV-1 IN throughout the simulation, ionic inter-
action seems to be a major reason why DKA is a more potent
inhibitor than 5CITEP.
Role of water molecules
It is well known that water molecules are important in bio-
logical systems, including in catalysis and in mediating ligand
binding. The x-ray structure of the HIV-1 IN-5CITEP com-
plex (20) revealed that four interfacial water molecules were
located close to Asp-64, Asp-116, and 5CITEP. These water
molecules as well as the side-chain oxygen atoms of both
aspartic residues were found to octahedrally coordinate the
Mg21 ion. The importance of these water molecules in HIV-
1 IN is uncertain. Based on an MD simulation study (29) of
the x-ray structure of the HIV-1 IN-5CITEP complex, it was
shown that water molecules present in the active site may be
crucial for bridging between the NH of indole ring of ligand
and carbonyl oxygen of Asp-64 and OD of Asn-155, through
hydrogen-bonding interactions.
FIGURE 10 Snapshots of the active site of HIV-1 IN-DKA complex (a)
and HIV-1 IN-5CITEP complex (b). Hydrogen-bonds and salt bridges are
indicated by dotted lines. All distances are in angstroms. The ﬁgures were
generated using VMD (54).
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In this study, our attention was focused on the two ‘‘cat-
alytic’’ water molecules (water No. 1 and water No. 2) coor-
dinated to the Mg21. The positions of both water molecules
were taken from the x-ray cocrystal structure of HIV-1 IN/
5CITEP (1QS4) i.e., water No. 226 and water No. 443. To
study the role of these water molecules, the hydrogen-bond
bridges between these water molecules and protein as well as
ligand were examined along the MD trajectories. The two
systems exhibited a somewhat similar pattern of bridging
water molecules between Asp-64, Asp-116, and the keto-
enolatemotif of the ligands (Fig. 10). These coordinatedwater
molecules did not signiﬁcantly move and did not exchange
with the bulk water. The hydrogen-bond bridges formed by
water molecules between the ligand and aspartic acids can
therefore stabilize the binding between inhibitors and HIV-
1 IN. It should be pointed out that a number of hydrogen-
bonds between the bridging water molecules and the protein,
as well as the ligand in IN-DKA,were larger that those seen in
the IN-5CITEP complex. In IN-DKA, both OD1 and OD2
atoms of Asp-64 and Asp-116 were involved in a hydrogen-
bond network with waters whereas only the OD1 atoms of
these two residues were hydrogen-bonded to the bridging
water in IN-5CITEP. Besides the bridging between protein
and ligand, these two water molecules sometimes mediated
hydrogen-bond bridges between Asp-64 and Asp-116.
Residue contributions
To elucidate the role of individual MM residues in stabilizing
or destabilizing the QM subsystem, an amino acid decom-
position analysis (52,53) was carried out as described below.
The QM/MM interaction energy, which consisted of elec-
trostatic and van derWaals terms, of each framewas computed.
Afterward, each MM residue was removed, one by one, and
the QM/MM interaction was recalculated. The contribution
of each individual amino acid is deﬁned in terms of the en-
ergy difference resulting from the residue deletion. Although,
the average contributions were examined from a set of 120
snapshots (at every 5 ps from 600 to 1200 ps), the results
should qualitatively estimate which amino acids signiﬁcantly
stabilize (positive) or destabilize (negative) the QM subsystem.
Fig. 11 shows the contributions of each MM residue in
stabilizing or destabilizing the QM part of the IN-DKA and
IN-5CITEP complexes. The standard deviations of each
residue contribution are given in Table 1. It should be pointed
out that the contributions of the stabilizing amino acids are
muchmore important than those of the destabilizing ones. For
both complexes, among all residues, Lys-159 exhibited the
greatest contribution in stabilizing the QM subsystem, as
indicated by its high interaction energy (;180 kcal/mol for
both systems). This stabilizing effect is mainly due to a strong
ionic interaction between the QM part and Lys-159, i.e., the
negatively charged group of ligand (carboxylate or tetrazo-
late) and the positively charged of ammonium group of Lys-
159. The remarkable differences between the two complexes
are the roles of Gln-62 and Leu-63. Gln-62 neither stabilizes
nor destabilizes the QM part in IN-DKA complex, however,
in IN-5CITEP, it plays a stabilizing role. Moreover, Leu-63
provides amajor destabilizing effect on the IN-DKA complex
whereas it yields a stabilizing effect on the IN-5CITEP com-
plex. This arises from the differential ability for forming
hydrogen-bonds between the O of Leu-63 and the NH ofAsp-
116 between the two complexes. Furthermore, the QMpart of
IN-DKA is stabilized by Thr-66 with a higher magnitude than
that observed in IN-5CITEP.ResiduesThr-115,Asn-117, and
Phe-121 play a critical role in stabilizing theQM subsystem in
both complexes. The roles of Cys-65, Gly-118, and Asn-155
in terms of stabilizing or destabilizing are unclear due to the
high values of their standard deviations.
CONCLUSION
There are two important aspects of the analysis of our results.
The ﬁrst one is the comparison of the results obtained from
conventional and mixed QM/MM MD simulations of IN-
5CITEP to determine whether classical MD is sufﬁcient and
FIGURE 11 Amino acid decomposition analysis showing contributions
of each individual MM amino acid to the QM subsystem. Stabilizing and
destabilizing interactions are represented as positive and negative energy values,
respectively. Only residues exhibiting an energy .1 kcal/mol are shown.
TABLE 1 Standard deviation (SD) of amino acid
decomposition analysis
Amino acid SD (kcal/mol)
IN-DKA IN-5CITEP
Gln-62 0.82 0.87
Leu-63 1.70 0.98
Cys-65 2.30 2.41
Thr-66 2.38 2.09
Thr-115 1.42 0.85
Asn-117 1.97 1.24
Gly-118 1.13 0.94
Phe-121 0.33 0.51
Asn-155 2.40 1.14
Lys-159 4.70 5.92
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suitable for the studied systems. Another aspect is how IN-
DKA and IN-5CITEP complexes differed in the QM/MM
simulations. Our results are consistent with the higher po-
tency of DKA as compared to 5CITEP.
Comparison of HIV-1 IN structures taken from classical
and QM/MM simulations reveals two notable differences
around residues 116–119 and 140–149. In the conventional
MD, residues 116–119 show high mobility, however, this loop
was quite rigid in the QM/MM simulation. This is probably
because in conventional MD, Gly-118 occasionally forms a
hydrogen-bond with Phe-121 and Thr-122 whereas in the
QM/MM study, it is always involved in a hydrogen-bond.
Moreover, differences in the dynamics of loop residues 140–
149 lead to substantially different orientations of key amino
acids, particularly Lys-159 in the a4-helix between the two
calculations. Another signiﬁcant difference between the two
levels of calculation is the coordination geometry of Mg21
which is found to be octahedral and distorted octahedral for
the MM and QM/MM simulations, respectively. In addition,
the bound positions of 5CITEP in the classical and QM/MM
MD simulations are quite different. In the MM study, the
ligand is positioned far from Lys-159, thus, it cannot form a
salt link with this residue. On the contrary, a salt bridge
between this amino acid and 5CITEP was detected in the
QM/MM study.
In addition, detailed structural analyses of the HIV-1 IN
complexed with either DKA or 5CITEP indicate that the pro-
tein and inhibitor in the two complexes display a different
dynamical behavior. Substantial structural differences were
found at: i), residues 60–68; ii), residues 116–119; and iii),
residues 140–149 (a ﬂexible loop). The IN-DKA complex ex-
hibits a shorter b1-sheet (60–66) than in the IN-5CITEP com-
plex (residues 60–68). Furthermore, loop residues 116–119 in
IN-DKA is much more curved than that seen in IN-5CITEP.
Moreover, the side chains of Asp-64 and Asp-116 in the two
systems are signiﬁcantly different resulting in a somewhat
different pattern of the distorted octahedral geometry of Mg21
between IN-DKA and IN-5CITEP systems. In the IN-DKA
complex, Asp-64 oriented its OD1 and OD2 atoms to chelate
the Mg21 in a monodentate conﬁguration whereas only the
OD1 is used to coordinate the divalent metal ion in the IN-
5CITEP complex. Moreover, both OD1 and OD2 belonging
to Asp-116 in IN-DKA are involved in water-mediated
hydrogen-bonding whereas only the OD1 of IN-5CITEP can
form a hydrogen-bond with a bridging water molecule.
The bound position of DKA and 5CITEP is somewhat sim-
ilar. The keto-enolate moiety directly interacts with the Mg21
whereas the carboxylate (for DKA) or tetrazolate (for 5CITEP)
is oriented toward residue Lys-159. Moreover, the keto-enolate
motif of both DKA and 5CITEP is indirectly hydrogen-bonded
toAsp-64 andAsp-116 via bridgingwater molecules. An anal-
ysis of the conformational dynamics of the ligand reveals
that the DKA conformation is quite rigid across the MD
simulation whereas the 5CITEP conformation exhibits high
mobility. Furthermore, a strong salt link between DKA and
HIV-1 IN existed for the entire course of the simulation
whereas that between 5CITEP and Lys-159 was weaker.
This means that ionic interactions were stronger in the IN-
DKA complex as compared with the IN-5CITEP system.
This supports experimentally observed the higher potency of
DKA as compared to 5CITEP. Amino acid energy decom-
position is also in support of the important role of Lys-159 in
the mechanism of action. In general, our study provides in-
sights into the detailed mechanism of action of DKA and
5CITEP and suggests why DKA is a more potent inhibitor,
when compared with 5CITEP, against HIV-1 IN.
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